The 5′ region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences†
Françoise Charbonnier
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorStephanie Baert-Desurmont
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorPing Liang
Department of Genetics, Roswell Park Cancer Institute, Buffalo, New York
Search for more papers by this authorFrederic Di Fiore
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Search for more papers by this authorCosette Martin
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorStephanie Frerot
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorSylviane Olschwang
Inserm U434 and Saint Antoine Hospital, Paris, France
Search for more papers by this authorMarie-Pierre Buisine
Laboratory of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France
Search for more papers by this authorBrigitte Gilbert
Department of Genetics, Poitiers University Hospital, Poitiers, France
Search for more papers by this authorMef Nilbert
Department of Oncology, University Hospital, Lund, Sweden
Search for more papers by this authorAnnika Lindblom
Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden
Search for more papers by this authorCorresponding Author
Thierry Frebourg
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Inserm U614-IFRMP, Faculty of Medicine, 22 Boulevard Gambetta, 76183 Rouen, FranceSearch for more papers by this authorFrançoise Charbonnier
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorStephanie Baert-Desurmont
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorPing Liang
Department of Genetics, Roswell Park Cancer Institute, Buffalo, New York
Search for more papers by this authorFrederic Di Fiore
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Search for more papers by this authorCosette Martin
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorStephanie Frerot
Department of Genetics, Rouen University Hospital, Rouen, France
Search for more papers by this authorSylviane Olschwang
Inserm U434 and Saint Antoine Hospital, Paris, France
Search for more papers by this authorMarie-Pierre Buisine
Laboratory of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France
Search for more papers by this authorBrigitte Gilbert
Department of Genetics, Poitiers University Hospital, Poitiers, France
Search for more papers by this authorMef Nilbert
Department of Oncology, University Hospital, Lund, Sweden
Search for more papers by this authorAnnika Lindblom
Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden
Search for more papers by this authorCorresponding Author
Thierry Frebourg
Inserm U614-IFRMP, Faculty of Medicine, Rouen, France
Department of Genetics, Rouen University Hospital, Rouen, France
Inserm U614-IFRMP, Faculty of Medicine, 22 Boulevard Gambetta, 76183 Rouen, FranceSearch for more papers by this authorCommunicated by Richard G.H. Cotton
Abstract
MSH2 rearrangements are involved in approximately 10% of hereditary non-polyposis colorectal cancer (HNPCC) families, and in most of the rearrangements, exon 1 is deleted. We scanned by quantitative multiplex polymerase chain reaction (PCR) of short fluorescent fragments (QMPSF) 200 kb of genomic sequences upstream of the MSH2 transcription initiation site in 21 HNPCC families with exon 1 deletions. This QMPSF scan revealed 12 distinct 5′ breakpoints located up to 200 kb upstream of the MSH2 transcription initiation site. Sequencing analysis of the rearranged allele in 17 families revealed that most of the deletions (15/17) resulted from homologous Alu-mediated recombination. QMPSF and sequencing analysis in these 21 families led us to detect the presence of 20 distinct 5′ breakpoints. In 14 out of 15 Alu-mediated recombinations, we found, either within the identical region in which the recombination had probably occurred or in its vicinity, the 26-bp Alu core sequence containing the recombinogenic Chi-like motif. Compared to the equivalent regions of other human genes, the MSH2 upstream region was found to contain a high density of Alu repeats (30% within 228 kb and 43% within 50 kb), most of which belong to the old Alu S subfamilies. In conclusion, this study demonstrates the heterogeneity of the breakpoints within the MSH2 upstream region and reveals the remarkable density of recombinogenic Alu sequences in this region. Hum Mutat 26(3), 255–261, 2005. © 2005 Wiley-Liss, Inc.
REFERENCES
- Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. 2003. Translocation and gross deletion breakpoints in human inherited disease and cancer. I: nucleotide composition and recombination-associated motifs. Hum Mutat 22: 229–244.
- Batzer MA, Deininger PL. 2002. Alu repeats and human genomic diversity. Nat Rev Genet 3: 370–379.
- Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, Shea-Simonds J, Duncan PJ, Curtis CE, Robinson DO, Harvey JF, Cross NC. 2004. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 13;91: 1155–1159.
- Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, Saurin JC, Puisieux A, Olschwang S, Frebourg T. 2000. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 60: 2760–2763.
- Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T. 2002. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 62: 848–853.
- Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol Genet Metab 67: 183–193.
- Di Fiore F, Charbonnier F, Martin C, Frerot S, Olschwang S, Wang Q, Boisson C, Buisine MP, Nilbert M, Lindblom A, Frebourg T. 2004. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 41: 18–20.
- Iwahashi Y, Ito E, Yanagisawa Y, Akiyama Y, Yuasa Y, Onodera T, Maruyama K. 1998. Promoter analysis of the human mismatch repair gene hMSH2. Gene 213: 141–147.
- Jurka J. 2004. Evolutionary impact of human Alu repetitive elements. Curr Opin Genet Dev 14: 603–608.
- Jurka J, Smith T. 1988. A fundamental division in the Alu family of repeated sequences. Proc Natl Acad Sci USA 85: 4775–4778.
- Kolomietz E, Meyn MS, Pandita A, Squire JA. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35: 97–112.
- Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860–921.
- Lucci-Cordisco E, Zito I, Gensini F, Genuardi M. 2003. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet 122A: 325–334.
- Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. 2004. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23: 5748–5758.
- Nakagawa H, Hampel H, de la Chapelle A. 2003. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 22: 258.
- Rudiger NS, Gregersen N, Kielland-Brandt MC. 1995. One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. Nucleic Acids Res 23: 256–260.
- Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR. 2003. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 22: 428–433.
- Vasen HF, Watson P, Mecklin JP, Lynch HT. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453–1456.
- Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. 2003. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72: 1088–1100.
- Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E. 2003. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLK1 genes. Int J Cancer 103: 636–641.